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Introduction
Anaphylaxis is a serious clinical condition that can affect 
all ages and many systems (skin, gastrointestinal system, 
respiratory and cardiovascular systems). Anaphylaxis 
causes the release of vasoactive chemical agents from 
mast cells (1,2). There are a few case reports of cardiac 
and cerebrovascular complications due to the anaphylaxis 
and/or the treatment with epinephrine. We present a 
case of cardiovascular complication and stroke following 
intramuscular (IM) adrenalin administration with 
anaphylactic diagnosis in this study.
Case report
A 69-year-old female patient with known coronary artery 
disease (CAD), coronary artery bypass graft (CABG), and 
diabetes mellitus (DM) was admitted to the emergency 
department. She was brought to the emergency service 
with the complaints of shortness of breath, swelling of the 
tongue and lip, widespread itching and nausea after the use 
of amoxicillin-clavulonic acid due to soft tissue infection. 
The vital signs of the patient included a blood pressure of 
90/60, pulse rate of 130/min, respiratory rate of 30/min, 
and O2 saturation with pulse oximeter of 90. On physical 
examination, the patient had pale, sweaty, and chronotropic 
appearance, in addition, bilateral bronchospasm was 
present in the lungs. The tongue and lips were swollen and 
edema was apparent. On first electrocardiography (ECG), 
there was no acute ischemic change at normal sinus 
rhythm of 120/min. The patient was considered as having 
anaphylaxis and she was monitored by opening the vein 
pathway. Intravenous (IV) fluid hydration and 0.5 mg IM 
epinephrine were administered. Besides, oxygen therapy 
(3-4 L/dk) was initiated. The patient was given salbutamol 
inhaler, an ampule antihistamine (pheniramine 22.7 
mg) and corticosteroid IV 80 mg (methylprednisolone). 
Consequently, her blood pressure improved. We reapplied 
0.3 mg of epinephrine IM for continuing tachypnea, 
abdominal pain and widespread itching. ECG monitoring 
in the emergency department showed a rate of 140/min 
and the rhythm was evaluated as atrial fibrillation. In D2-
D3-aVF, V5-V6 a nonspecific ST-T change was developed 
and the patient was consulted to cardiology department 
with the initial diagnosis of coronary vasospasm due to 
allergic reaction. No acute pathology was detected on 
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Abstract
Anaphylaxis is a serious clinical condition that can affect all ages and many systems (skin, 
gastrointestinal system, respiratory and cardiovascular systems). There are a few case reports 
of cardiac and cerebrovascular complications due to the anaphylaxis and/or the treatment 
with epinephrine. A 69-year-old female patient with known coronary artery disease (CAD), 
coronary artery bypass graft (CABG), and diabetes mellitus (DM) was admitted to the 
emergency department. She was brought to the emergency service with the complaints of 
shortness of breath, swelling of the tongue and lip, widespread itching and nausea after the 
use of amoxicillin-clavulonic acid due to soft tissue infection. The patient was considered as 
having anaphylaxis. 0.5 mg intramuscular (IM) epinephrine was administered. Following the 
emergency electrocardiography (ECG), the rate was 140/min and the rhythm was evaluated as 
atrial fibrillation. We present a case of cardiovascular complications and acute ischemia stroke 
following intramuscular epinephrine administration with anaphylactic diagnosis in this study. 
As a result, anaphylaxis management is extremely important in elderly patients with preexisting 
cardiovascular conditions.
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echocardiography. No serious abnormal findings were 
found in patient’s blood tests and cardiac enzymes were 
negative. In the follow-up of the patient, he developed 
speech impairment and weakness in the right upper 
extremity. On neurological examination, the patient had 
facial asymmetry and right upper extremity 1/5 motor 
deficit. Within about 30 minutes, motor deficit gradually 
improved. In the emergency department, the motor 
deficit in the right upper extremity was 4/5. Cerebral 
diffuse magnetic resonance imaging revealed a lesion 
in the left middle cerebral artery and posterior cerebral 
artery compatible with acute infarction (Figure 1). The 
patient was referred to the center for intensive care by 
the neurology department with the diagnosis of acute 
ischemic stroke.
Discussion
Anaphylaxis is life threatening medical emergency. 
Previously, brain damage have been described in the 
anaphylaxis and anaphylactic shock (3). Vasoactive 
mediators released by anaphylaxis (histamine, tumor 
necrosis factor-alpha, heparin and neutral proteases) are 
reported to contribute to blood-brain barrier damage, 
brain edema, prolonged extravasation and haemorrhage 
(4). Early application of epinephrine is extremely 
important to prevent anaphylactic side effects from 
progressing to life-threatening conditions. However, 
problems such as cerebral perfusion disorder and cerebral 
ischemia due to vasospasm have been reported especially 
due to intravenous use of adrenaline (5,6). Evidence shows 
that arterial hypotension may also impair cerebral blood 
flow. In the study of Davidson et al, cerebral ischemia 
and cerebral damage following anaphylactic shock were 
reported not to be due to arterial hypotension but to be 
directly influenced by anaphylactic mediators on the 
cerebral artery system (7).
Similarly, the underlying mechanism of anaphylactic 
cardiac complications (acute coronary syndrome, 
myocardial infarction, arrhythmia, myocarditis, etc) is 
independent of the etiology (vasoactive mediators and 
catecholamine release, vasospasm and microvascular 
dysfunction). In addition, the use of epinephrine will 
increase the potential for the development of arrhythmias. 
The incidence of cardiovascular complications due to the 
use of IV epinephrine is especially higher. Therefore, the 
use of IM is highly recommended (1,2).
Three factors may have contributed to the development 
of cardiac and cerebrovascular complications in our 
case. These include (a) anaphylaxis and vasochemical 
mediators released, (b) arterial hypotension due to 
anaphylaxis in the patient, and (c) sympathetic effect of 
epinephrine. It is difficult to analyze exactly what triggers 
these, but the emergence of these complications especially 
after epinephrine is more prominent than others. It is 
also important that the patient is old and has a previous 
cardiac disease history. The use of epinephrine in elderly 
patients with CAD as well as the concern about the 
potential cardiac effects are important and should be well 
considered against the risk of untreated anaphylaxis.
Therefore, anaphylaxis management is extremely 
important in elderly patients with preexisting 
cardiovascular conditions. Particular attention should 
be paid to the use of epinephrine and cardiac and 
cerebrovascular complications that may develop in the 
anaphylactic patients. Emergency physicians should have 
information about these outcomes.
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Figure 1. Cerebral diffuse magnetic resonance showed a lesion in 
the left middle cerebral artery and posterior cerebral artery that was 
compatible with acute infarction. 
Abbreviations: DWI, diffusion-weighted imaging; ADC, Apparent 
diffusion coefficient.
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